Disclaimer
Disclosure – Non-Independent Marketing Communication
This is a non-independent marketing communication commissioned by Bellevue Healthcare. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.
- Over the financial year ending 30 November 2020, BBH’s NAV total return (including dividends reinvested) was 22.5%, representing a significant outperformance of the comparator index (the MSCI World Healthcare total return Index) which produced a total return of 10.3%.
- The trust has a target dividend equal to 3.5% of preceding year-end NAV, paid out in two installments. In the last financial year, the board paid total dividend of 5p. The board has proposed a total dividend of 6.03p for the financial year ending 30 November 2021.
The team at BBH are cautious about the outlook in 2021, with the performance of the sector hinging on a range of factors, including US policies and vaccine rollouts. However, the long-term underlying growth trajectory of the trust has been unimpacted in 2020, with innovation and disruption creating investment opportunities for the manager going forward.
Kepler Trust Intelligence provides research and information for professional and private investors. In order to ensure that we provide you with the right kind of content, and to ensure that the content we provide is compliant, you need to tell us what type of investor you are.
Continue